APA (7th ed.) Citation

YC, L., CC, H., YL, L., & CY, L. (2018). Molecular Markers and Prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis. Clinical lymphoma, myeloma & leukemia, 18(9), 558. https://doi.org/10.1016/j.clml.2018.06.004

Chicago Style (17th ed.) Citation

YC, Lee, Hsieh CC, Lee YL, and Li CY. "Molecular Markers and Prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis." Clinical Lymphoma, Myeloma & Leukemia 18, no. 9 (2018): 558. https://doi.org/10.1016/j.clml.2018.06.004.

MLA (9th ed.) Citation

YC, Lee, et al. "Molecular Markers and Prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis." Clinical Lymphoma, Myeloma & Leukemia, vol. 18, no. 9, 2018, p. 558, https://doi.org/10.1016/j.clml.2018.06.004.